Matt Rudd

Dr. Matt Rudd is a medical researcher affiliated with Newcastle University, specializing in clinical decision-making processes for thrombolysis in acute ischaemic stroke treatment. His work focuses on understanding variations in clinical practice and developing discrete choice experiments (DCEs) to evaluate decision-making frameworks.

• Collaborated with multidisciplinary teams including Prof Laura Ternent, Prof Christopher Price, and Emerita Prof Helen Rodgers
• Research spans 2014–2018 with publications analyzing thrombolysis criteria and clinician preferences

Key methodologies involve DCEs, a quantitative technique for measuring clinician preferences and trade-offs in complex medical scenarios. His studies aim to improve consistency in stroke treatment protocols and inform healthcare policy.